BioDelivery Sciences investor CDC IV sells shares, keeps 16.2% stake

By Lisa Kerner

Charlotte, N.C., June 26 - A group of BioDelivery Sciences International, Inc. shareholders led by CDC IV, LLC sold 95,981 shares of the company's stock between June 22 and June 25 priced from $6.30 to $6.60 each, according to a schedule 13D/A filed with the Securities and Exchange Commission on Friday.

The investor beneficially owns 3,530,134 shares, including warrants, or 16.2%, of the Morrisville, N.C.-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.